Result of Annual General Meeting

Biodexa Pharmaceuticals reported the results of its re-scheduled Annual General Meeting, where ordinary resolutions 1 through 7 passed with majorities ranging from 73% to 94%. Ordinary resolution 8 and special resolution 10 failed to secure approval, resulting in the failure of resolution 11 which was contingent on the passing of resolution 8.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.